Carcinoma de Pulmón No Microcítico (CPNM) EGFRm+: identificación de los pacientes con mutación T790M

16 / 23

(A) Patients with T790M+ tumors have a dramatically longer PFS than do patients with T790M2 tumors (P , .001). (B) Plasma genotyping for T790M fails to identify two subgroups with different PFS (P = .188).